“I highly enjoy working at PrognomiQ, with visionary and open-minded leaders, and colleagues who are friendly and welcome. We’re using the latest cutting-edge technology as we develop new cancer diagnostics.”
PrognomiQ Inc
生物技术研究
San Mateo，California 7,351 位关注者
Transform healthcare and early disease detection through the power of multi-omics data.
Meet our Leaders
About PrognomiQ
At PrognomiQ, we aim to transform healthcare by generating and using systems biology data to develop and commercialize tests for early detection and treatment of cancer and other complex diseases. PrognomiQ leverages leading proteomics technology, including the Proteograph product suite from Seer as part of a multi-omics platform that provides an unprecedented molecular view of health and disease. We are a team of experienced and accomplished scientists supported by a group of leading investors.
Check out our careers!Our Technology
PrognomiQ leverages the latest advances in proteomics to generate direct information of a person’s biological state, including state of disease. This rich proteomic information can be further complemented by additional data sources including genomics and metabolomics. The resulting multi-omics data sets provide unparalleled levels of biological insights, including on the mechanisms of the most complex diseases.
Life at PrognomiQ
In everything we do, we strive to make a meaningful impact. Our team is cross functional and multidisciplinary. We value passion, collaboration, and the desire to tackle the toughest scientific and clinical challenges with confidence and humility. Join us as we open new doorways into disease detection and treatment.